Roche

A man walks next to a sign for the Roche Holding AG headquarters on April 11, 2025 in Basel, Switzerland. Before US President Donald Trump postponed a range of imminent tariffs, Switzerland was facing a daunting 31% levy on most Swiss goods to imported to the United States, a higher rate than would have been imposed on European Union countries. Such a tariff would've been high damaging to iconic Swiss industries like chocolate and watchmaking. The reprieve will provide breathing room for Swiss officials looking to negotiate a deal with the US, although Swiss goods will still face a 10% tariff in the meantime, and the fate of a potential separate tariff on pharmaceuticals is unknown.
Health

Swiss drugmaker Roche leans into Trump tariff formula with $50 billion promise to invest in U.S.

By
April 22, 2025
Roche, Zealand Pharma in $5.3 billion pact for obesity drugs
Retail

Roche, Zealand Pharma in $5.3 billion pact for obesity drugs

By Paula Doenecke, Naomi Kresge and Bloomberg
March 12, 2025
A young woman undergoes a brain scan.
Aging Well

Meet the 24-year-old helping Lilly test a preventive Alzheimer’s drug

By
February 6, 2025
Eli Lilly & Co., the Fortune 500 pharma firm that manufactures weight-loss injection Zepbound (tirzepatide), has a comparable oral medication in the works that could be approved by the FDA as early as 2026, CEO Dave Ricks told Bloomberg TV on Jan. 13, 2025.
Health

Hate needles? Lilly’s weight-loss pill could get FDA approval next year, CEO says

By
January 22, 2025
Roche stock is falling after report its Wegovy challenger is causing patients to vomit
Health

Roche stock is falling after report its Wegovy challenger is causing patients to vomit

By Naomi Kresge and Bloomberg
September 12, 2024
Thomas Schinecker, chief executive officer of Roche
Finance

Swiss pharma giant Roche is ‘fast-tracking’ development of an experimental Wegovy challenger pill for weight loss

By
July 29, 2024
Thomas Schinecker, CEO of Roche Holding.
Retail

An obesity pill study tested on just 25 patients led to a stunning $16.8 billion increase in Swiss drugmaker Roche’s market value

By Naomi Kresge, Lisa Pham and Bloomberg
July 23, 2024
Thomas Schinecker, chief executive officer of Roche Holding
Finance

Switzerland shouldn’t follow Europe’s lead on tax, says Roche CEO. Instead, it must compete with ‘Dubai, China and India’

By Paula Doenecke and Bloomberg
May 14, 2024
Pascal Soriot, chief executive officer of Astrazeneca Plc, arrives at the CEO council at the Great Hall of the People in Beijing, Chin
Success

Major investors say AstraZeneca boss is ‘massively underpaid’ on $21.5 million salary, despite earning more than double Novo Nordisk’s CEO

By
April 10, 2024
Stock traders from various companies work in five circular and one semi-circular trading floor at the Frankfurt Stock Exchange.
Finance

Meet Europe’s answer to the ‘Magnificent 7’—the high-flying ‘Granolas’ that Goldman Sachs is betting will prosper in the continent’s flatlining economy

By
March 3, 2024
Roche pushes to catch up to Novo Nordisk’s Wegovy with $3.1bn deal for obesity drugmaker Carmot
Finance

Roche pushes to catch up to Novo Nordisk’s Wegovy with $3.1bn deal for obesity drugmaker Carmot

By Paula Doenecke and Bloomberg
December 4, 2023
Drug trial
Health

Roche is using AI to find the hardest-to-find lung cancer patients, with a potential blockbuster drug on the line

By Naomi Kresge and Bloomberg
October 22, 2023
Why a biotech firm’s market value jumped from $3 million to $130 million in a day and is still way up from its ‘almost unfathomably low valuation’
Health

Why a biotech firm’s market value jumped from $3 million to $130 million in a day and is still way up from its ‘almost unfathomably low valuation’

By Angel Adegbesan and Bloomberg
October 13, 2023
Market trader recession

A top Wall Street strategist changes his tune and says the U.S. can now avoid a recession

By
June 20, 2022
Woman using home COVID-19 testing kit on her teenage daughter.
Health

Here’s when to expect at-home tests that are better at detecting Omicron

By
January 18, 2022

Most Popular